Oncology Based Molecular Diagnostics Market Size, Share & Trends Analysis Report By Type (Breast Cancer, Lung Cancer), By Product (Instruments, Reagents), By Technology (PCR, Sequencing), By Region, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                        1.1.1. Type
                        1.1.2. Product
                        1.1.3. Technology
                        1.1.4. Regional scope
                        1.1.5. Estimates and forecast timeline
                    1.2. Research Methodology
                    1.3. Information Procurement
                        1.3.1. Purchased database
                        1.3.2. GVR’s internal database
                        1.3.3. Secondary sources
                        1.3.4. Primary research
                        1.3.5. Details of primary research
                    1.4. Information or Data Analysis
                        1.4.1. Data analysis models
                    1.5. Market Formulation & Validation
                    1.6. Model Details
                    1.7. List of Secondary Sources
                    1.8. List of Primary Sources
                    1.9. Objectives
                        1.9.1. Objective 1
                        1.9.2. Objective 2
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Type outlook
                        2.2.2. Product outlook
                        2.2.3. Technology outlook
                        2.2.4. Regional outlook
                    2.3. Competitive Insights
Chapter 3. Oncology Based Molecular Diagnostics Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Related/Ancillary Market outlook
                    3.2. Penetration & Growth Prospect Mapping
                    3.3. Market Dynamics
                        3.3.1. Market Driver Analysis
                        3.3.2. Market Restraint Analysis
                    3.4. Oncology Based Molecular Diagnostics Market Analysis Tools
                        3.4.1. Industry Analysis - Porter’s Five Forces
                            3.4.1.1. Supplier power
                            3.4.1.2. Buyer power
                            3.4.1.3. Substitution threat
                            3.4.1.4. Threat of new entrant
                            3.4.1.5. Competitive rivalry
                        3.4.2. PESTEL Analysis
                            3.4.2.1. Political landscape
                            3.4.2.2. Technological landscape
                            3.4.2.3. Economic landscape
Chapter 4. Oncology Based Molecular Diagnostics Market: Type Estimates & Trend Analysis
                    4.1. Oncology Based Molecular Diagnostics Market: Key Takeaways
                    4.2. Oncology Based Molecular Diagnostics Market: Type Movement & Market Share Analysis, 2022 & 2030
                    4.3. Breast Cancer
                        4.3.1. Breast cancer market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.4. Prostate Cancer
                        4.4.1. Prostate cancer market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.5. Colorectal Cancer
                        4.5.1. Colorectal cancer market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.6. Cervical Cancer
                        4.6.1. Cervical cancer market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.7. Liver Cancer
                        4.7.1. Liver cancer market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.8. Lung Cancer
                        4.8.1. Lung cancer market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.9. Blood Cancer
                        4.9.1. Blood cancer market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.10. Kidney Cancer
                        4.10.1. Kidney cancer market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.11. Other Cancer
                        4.11.1. Others cancer market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Oncology Based Molecular Diagnostics Market: Product Estimates & Trend Analysis
                    5.1. Oncology Based Molecular Diagnostics Market: Key Takeaways
                    5.2. Oncology Based Molecular Diagnostics Market: Product Movement & Market Share Analysis, 2022 & 2030
                    5.3. Instruments
                        5.3.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
                    5.4. Reagents
                        5.4.1. Reagents market estimates and forecasts, 2018 to 2030 (USD Million)
                    5.5. Others
                        5.5.1. Other products market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Oncology Based Molecular Diagnostics Market: Technology Estimates & Trend Analysis
                    6.1. Oncology Based Molecular Diagnostics Market: Key Takeaways
                    6.2. Oncology Based Molecular Diagnostics Market: Technology Movement & Market Share Analysis, 2022 & 2030
                    6.3. PCR
                        6.3.1. PCR market estimates and forecasts, 2018 to 2030 (USD Million)
                    6.4. In situ hybridization
                        6.4.1. In situ hybridization market estimates and forecasts, 2018 to 2030 (USD Million)
                    6.5. INAAT
                        6.5.1. INAAT market estimates and forecasts, 2018 to 2030 (USD Million)
                    6.6. Chips and microarrays
                        6.6.1. Chips and microarrays market estimates and forecasts, 2018 to 2030 (USD Million)
                    6.7. Mass spectrometry
                        6.7.1. Mass spectrometry market estimates and forecasts, 2018 to 2030 (USD Million)
                    6.8. Sequencing
                        6.8.1. Sequencing market estimates and forecasts, 2018 to 2030 (USD Million)
                    6.9. TMA
                        6.9.1. TMA market estimates and forecasts, 2018 to 2030 (USD Million)
                    6.10. Others
                        6.10.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Oncology Based Molecular Diagnostics Market: Regional Estimates & Trend Analysis
                    7.1. Regional Outlook
                    7.2. Oncology Based Molecular Diagnostics Market by Region: Key Takeaways
                    7.3. North America
                        7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        7.3.2. U.S.
                            7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        7.3.3. Canada
                            7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                    7.4. Europe
                        7.4.1. U.K.
                            7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        7.4.2. Germany
                            7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        7.4.3. France
                            7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        7.4.4. Italy
                            7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        7.4.5. Spain
                            7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        7.4.6. Sweden
                            7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        7.4.7. Norway
                            7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        7.4.8. Denmark
                            7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                    7.5. Asia Pacific
                        7.5.1. Japan
                            7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        7.5.2. China
                            7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        7.5.3. India
                            7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        7.5.4. Australia
                            7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        7.5.5. Thailand
                            7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        7.5.6. South Korea
                            7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                    7.6. Latin America
                        7.6.1. Brazil
                            7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        7.6.2. Mexico
                            7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        7.6.3. Argentina
                            7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                    7.7. MEA
                        7.7.1. Saudi Arabia
                            7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        7.7.2. South Africa
                            7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        7.7.3. UAE
                            7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        7.7.4. Kuwait
                            7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
                    8.1. Recent Developments & Impact Analysis, By Key Market Participants
                    8.2. Company/Competition Categorization
                        8.2.1. Abbott
                            8.2.1.1. Company overview
                            8.2.1.2. Financial performance
                            8.2.1.3. Product benchmarking
                            8.2.1.4. Strategic initiatives
                        8.2.2. Bayer AG
                            8.2.2.1. Company overview
                            8.2.2.2. Financial performance
                            8.2.2.3. Product benchmarking
                            8.2.2.4. Strategic initiatives
                        8.2.3. BD
                            8.2.3.1. Company overview
                            8.2.3.2. Financial performance
                            8.2.3.3. Product benchmarking
                            8.2.3.4. Strategic initiatives
                        8.2.4. Cepheid
                            8.2.4.1. Company overview
                            8.2.4.2. Financial performance
                            8.2.4.3. Product benchmarking
                            8.2.4.4. Strategic initiatives
                        8.2.5. Agilent Technologies, Inc.
                            8.2.5.1. Company overview
                            8.2.5.2. Financial performance
                            8.2.5.3. Product benchmarking
                            8.2.5.4. Strategic initiatives
                        8.2.6. Danaher
                            8.2.6.1. Company overview
                            8.2.6.2. Financial performance
                            8.2.6.3. Product benchmarking
                            8.2.6.4. Strategic initiatives
                        8.2.7. Hologic, Inc.
                            8.2.7.1. Company overview
                            8.2.7.2. Financial performance
                            8.2.7.3. Product benchmarking
                            8.2.7.4. Strategic initiatives
                        8.2.8. Qiagen
                            8.2.8.1. Company overview
                            8.2.8.2. Financial performance
                            8.2.8.3. Product benchmarking
                            8.2.8.4. Strategic initiatives
                        8.2.9. F. Hoffmann-La Roche Ltd.
                            8.2.9.1. Company overview
                            8.2.9.2. Financial performance
                            8.2.9.3. Product benchmarking
                            8.2.9.4. Strategic initiatives
                        8.2.10. Siemens
                            8.2.10.1. Company overview
                            8.2.10.2. Financial performance
                            8.2.10.3. Product benchmarking
                            8.2.10.4. Strategic initiatives
                        8.2.11. Sysmex
                            8.2.11.1. Company overview
                            8.2.11.2. Financial performance
                            8.2.11.3. Product benchmarking
                            8.2.11.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 North America Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 3 North America Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 4 North America Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 5 North America Oncology Based Molecular Diagnostics Market, by Region, 2018 - 2030 (USD Million)
Table 6 U.S. Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 7 U.S. Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 8 U.S. Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 9 Canada Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 10 Canada Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 11 Canada Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 12 Europe Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 13 Europe Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 14 Europe Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 15 Europe Oncology Based Molecular Diagnostics Market, by Region, 2018 - 2030 (USD Million)
Table 16 Germany Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 17 Germany Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 18 Germany Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 19 UK Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 20 UK Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 21 UK Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 22 France Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 23 France Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 24 France Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 25 Italy Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 26 Italy Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 27 Italy Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 28 Spain Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 29 Spain Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 30 Spain Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 31 Sweden Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 32 Sweden Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 33 Sweden Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 34 Norway Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 35 Norway Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 36 Norway Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 37 Denmark Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 38 Denmark Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 39 Denmark Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 40 Asia Pacific Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 41 Asia Pacific Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 42 Asia Pacific Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 43 Asia Pacific Oncology Based Molecular Diagnostics Market, by Region, 2018 - 2030 (USD Million)
Table 44 China Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 45 China Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 46 China Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 47 Japan Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 48 Japan Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 49 Japan Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 50 India Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 51 India Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 52 India Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 53 Thailand Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 54 Thailand Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 55 Thailand Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 56 South Korea Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 57 South Korea Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 58 South Korea Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 59 Australia Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 60 Australia Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 61 Australia Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 62 Latin America Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 63 Latin America Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 64 Latin America Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 65 Latin America Oncology Based Molecular Diagnostics Market, by Region, 2018 - 2030 (USD Million)
Table 66 Brazil Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 67 Brazil Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 68 Brazil Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 69 Mexico Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 70 Mexico Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 71 Mexico Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 72 Argentina Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 73 Argentina Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 74 Argentina Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 76 Middle East and Africa Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 77 Middle East and Africa Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa Oncology Based Molecular Diagnostics Market, by Region, 2018 - 2030 (USD Million)
Table 79 South Africa Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 80 South Africa Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 81 South Africa Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 85 UAE Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 86 UAE Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 87 UAE Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 88 Kuwait Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 89 Kuwait Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
Table 90 Kuwait Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Oncology based molecular diagnostics market: market outlook
Fig. 9 Oncology based molecular diagnostics market competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Oncology based molecular diagnostics market driver impact
Fig. 15 Oncology based molecular diagnostics market restraint impact
Fig. 16 Oncology based molecular diagnostics market strategic initiatives analysis
Fig. 17 Oncology based molecular diagnostics market: type movement analysis
Fig. 18 Oncology based molecular diagnostics market: type outlook and key takeaways
Fig. 19 Breast cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Colorectal cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Cervical cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Liver cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Lung cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Blood cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Kidney cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Other cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Oncology based molecular diagnostics market: product movement analysis
Fig. 29 Oncology based molecular diagnostics market: product outlook and key takeaways
Fig. 30 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Oncology based molecular diagnostics market: technology movement analysis
Fig. 34 Oncology based molecular diagnostics market: technology outlook and key takeaways
Fig. 35 PCR market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 In Situ Hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 INAAT market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Chips and microarrays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Mass spectrometry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 TMA market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Global oncology based molecular diagnostics market: regional movement analysis
Fig. 44 Global oncology based molecular diagnostics market: regional outlook and key takeaways
Fig. 45 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)